METTL17 抗体 (AA 129-429)
The 兔 多克隆 anti-METTL17 antibody is suitable to detect METTL17 in samples from 人. It has been validated for WB, ELISA, ICC 和 IF.
产品编号 ABIN7870440
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for METTL17 抗体 (AA 129-429) (ABIN7870440)
抗原
See all METTL17 抗体
METTL17
(Methyltransferase Like 17 (METTL17))
适用
人
宿主
兔
克隆类型
多克隆
标记
This METTL17 antibody is un-conjugated
应用范围
Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)
-
-
抗原表位
- AA 129-429
-
原理
- METTL17 Antibody / Methyltransferase-like protein 17
-
纯化方法
- Immunogen affinity purified
-
免疫原
- E.coli-derived human METTL17 recombinant protein (Position: K129-R429) was used as the immunogen for the METTL17 antibody.
-
亚型
- IgG
-
-
anti-Methyltransferase Like 17 (METTL17) (AA 88-116), (N-Term) antibody
METTL17 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB25675 unconjugated
anti-Methyltransferase Like 17 (METTL17) antibodyMETTL17 适用: 人, 小鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal dilution of the METTL17 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL
-
缓冲液
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- After reconstitution, the METTL17 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- METTL17 (Methyltransferase Like 17 (METTL17))
-
别名
- METTL17
-
背景
-
METTL17 antibody detects Methyltransferase-like protein 17, a mitochondrial RNA methyltransferase that contributes to the biogenesis and function of mitochondrial ribosomes. METTL17 catalyzes methylation of specific rRNA nucleotides, a process essential for proper ribosomal assembly and translational fidelity within mitochondria. This enzyme is part of the large family of S-adenosylmethionine-dependent methyltransferases, many of which regulate gene expression and RNA stability. The METTL17 antibody is widely used to study mitochondrial gene expression, translation, and the broader methyltransferase network involved in RNA modification and energy metabolism.
METTL17 is encoded by the METTL17 gene located on human chromosome 11q24.2. The protein localizes primarily to the mitochondrial matrix, where it associates with mitochondrial ribosomal subunits. Structurally, METTL17 contains a conserved Rossmann-like fold typical of class I methyltransferases, which facilitates binding to S-adenosyl-L-methionine (SAM), the universal methyl donor. Loss of METTL17 function impairs mitochondrial translation, leading to reduced oxidative phosphorylation and energy production.
The METTL17 antibody is useful in identifying both endogenous and overexpressed protein in cell lysates. Western blot typically reveals a single band around 44i 1/246 kDa corresponding to full-length METTL17. Immunofluorescence analysis demonstrates mitochondrial localization with co-staining of mitochondrial markers such as TOM20 or COX IV. Functional studies have shown that METTL17 interacts with mitochondrial ribosomal RNA and components of the large ribosomal subunit, supporting its role in rRNA modification and mitoribosome assembly.
Defects in METTL17-mediated methylation have been linked to disrupted mitochondrial respiration and altered cellular energy metabolism. In addition to its mitochondrial functions, METTL17 expression has been observed in proliferating cells and certain cancer tissues, suggesting potential links between RNA methylation and tumor metabolism. NSJ Bioreagents provides a validated METTL17 antibody for western blot, immunofluorescence, and immunoprecipitation applications, enabling detailed characterization of mitochondrial RNA processing and the effects of METTL17 on bioenergetics and translation regulation. -
UniProt
- Q9H7H0
抗原
-
You are here:
